Ticker Symbol | Entity Name | As Of Date | Company Name | Followers | Employees on Linkedin | Link | Industry | Date Added | Date Updated | Description | Website | Specialities | Logo | HQ.Street | HQ.City | HQ.State | HQ.Country | HQ.Postal | Headcount change in past 24 months | Company Name | Sector | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
private:partnershipforcompassionateusetherapies-2 | 1476703 | May 31st, 2019 12:00AM | Partnership for Compassionate Use Therapies | 22 | 0.00 | Open | Biotechnology | May 30th, 2019 08:33PM | May 30th, 2019 08:33PM | Partnership for Compassionate Use Therapies (PCUT) is a non-profit promoter of clinical trials of therapies for rare, life-threatening diseases. The company identifies existing products that have demonstrated high human tolerability and that show potential for efficacy in diseases where there is an unmet medical need. PCUT works with disease-specific foundations and with patient advocacy organizations to find programs that could, within 12 months, be brought to a Phase II trial in a rare disease. As opposed to the long march toward a “cure”, we are dedicated to quickly examining products that are potentially effective right now —even when such therapy might merely extend life and not necessarily “cure” patients. We are supported by charitable foundations and by individual families. We do not transfer funds to other organizations, but instead use every dollar for our own programs to bring developmental drugs directly to the clinic. | Open | De-Risking Clinical Development Programs, Social Capital Markets, Near Term Treatment Development for Rare Diseases, Patient Advocacy | Open | Partnership for Compassionate Use Therapies | Pharmaceuticals & Biotechnology | |||||||
private:partnershipforcompassionateusetherapies-2 | 1476703 | Nov 7th, 2017 12:00AM | Partnership for Compassionate Use Therapies | 19 | 0.00 | Open | Biotechnology | Nov 7th, 2017 04:24PM | Nov 7th, 2017 04:24PM | Partnership for Compassionate Use Therapies (PCUT) is a non-profit promoter of clinical trials of therapies for rare, life-threatening diseases. The company identifies existing products that have demonstrated high human tolerability and that show potential for efficacy in diseases where there is an unmet medical need. PCUT works with disease-specific foundations and with patient advocacy organizations to find programs that could, within 12 months, be brought to a Phase II trial in a rare disease. As opposed to the long march toward a “cure”, we are dedicated to quickly examining products that are potentially effective right now —even when such therapy might merely extend life and not necessarily “cure” patients. We are supported by charitable foundations and by individual families. We do not transfer funds to other organizations, but instead use every dollar for our own programs to bring developmental drugs directly to the clinic. | Partnership for Compassionate Use Therapies | Pharmaceuticals & Biotechnology | ||||||||||
private:partnershipforcompassionateusetherapies-2 | 1476703 | Nov 1st, 2017 12:00AM | Partnership for Compassionate Use Therapies | 19 | 0.00 | Open | Biotechnology | Nov 1st, 2017 04:07AM | Nov 1st, 2017 04:07AM | Partnership for Compassionate Use Therapies (PCUT) is a non-profit promoter of clinical trials of therapies for rare, life-threatening diseases. The company identifies existing products that have demonstrated high human tolerability and that show potential for efficacy in diseases where there is an unmet medical need. PCUT works with disease-specific foundations and with patient advocacy organizations to find programs that could, within 12 months, be brought to a Phase II trial in a rare disease. As opposed to the long march toward a “cure”, we are dedicated to quickly examining products that are potentially effective right now —even when such therapy might merely extend life and not necessarily “cure” patients. We are supported by charitable foundations and by individual families. We do not transfer funds to other organizations, but instead use every dollar for our own programs to bring developmental drugs directly to the clinic. | Partnership for Compassionate Use Therapies | Pharmaceuticals & Biotechnology |